Confidence dives as UK scraps drug pricing scheme
LONDON (Reuters) - Pharmaceutical companies have lost confidence in investing in Britain following a decision by the government to scrap a 50-year-old drug pricing mechanism, according to a survey released on Thursday.
<p><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=SHn61H" border="0"></img> (http://feeds.reuters.com/~a/reuters/healthNews?a=SHn61H)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/healthNews?i=GsU898F" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=GsU898F) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=HvbXCuf" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=HvbXCuf) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=GyK0rVf" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=GyK0rVf)
</div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/254619527" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/254619527/idUSL1980556920080320